The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance
Open accessAbstract
Escherichia coli represents an incredible versatile and diverse enterobacterial species and can be subdivided into the following; (i) intestinal non-pathogenic, commensal isolates. (ii) Intestinal pathogenic isolates and (iii) extraintestinal pathogenic E. coli or ExPEC isolates. The presence to several putative virulence genes has been positively linked with the pathogenicity of ExPEC. E. coli remains one of the most frequent causes of nosocomial and community-acquired bacterial infections including urinary tract infections, enteric infections, and systemic infections in humans. ExPEC has emerged in 2000s as an important player in the resistance to antibiotics including the cephalosporins and fluoroquinolones. Most importantly among ExPEC is the increasing recognition of isolates producing "newer β-lactamases" that consists of plasmid-mediated AmpC β-lactamases (e.g., CMY), extended-spectrum β-lactamases (e.g., CTX-M), and carbapenemases (e.g., NDM). This review will highlight aspects of virulence associated with ExPEC, provide a brief overview of plasmid-mediated resistance to β-lactams including the characteristics of the successful international sequence types such as ST38, ST131, ST405, and ST648 among ExPEC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Self-citationThe epidemiology of urinary tract infection
Foxman, B. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.190 · Cited by 1,771
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Mandell, Douglas, and Bennett's principles and practice of infectious diseases
Gillespie, S. H. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70159-6 · Cited by 705
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Self-citationThe emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Origins and virulence mechanisms of uropathogenic Escherichia coli
Wiles, T. J., Kulesus, R. R., & Mulvey, M. A. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.007 · Cited by 606
Herzer, P. J., Inouye, S., Inouye, M., & Whittam, T. S. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6175-6181.1990 · Cited by 533
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
Livermore, D. M., & Woodford, N. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.008 · Cited by 510
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Kaper, J. B. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.06.008 · Cited by 486
Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-06 · Cited by 461
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443 · cited 6×
“This review will highlight aspects of virulence associated with ExPEC, provide a brief overview of plasmid-mediated resistance to β-lactams including the characteristics of the successful international sequence types such as ST38, ST131, ST405, and ST648 among ExPEC.”
BackgroundInfluentialSelf-citationHornsey, M., Phee, L., & Wareham, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05108-11 · Cited by 392
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Cortés, P., Blanc, V., Mora, A., Dahbi, G., Blanco, J. E., Blanco, M., López, C., Andreu, A., Navarro, F., Alonso, M. P., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02421-09 · Cited by 218
Deshpande, P., Rodrigues, C. S., Shetty, A., Kapadia, F. N., Hedge, A., & Soman, R. N. (2010) · PubMed · Cited by 196
Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr299 · Cited by 188
Pai, H., Kang, C.-I., Byeon, J.-H., Lee, K.-D., Park, W. B., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3720-3728.2004 · Cited by 183
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
Self-citation(Patho-)Genomics of Escherichia coli
Dobrindt, U. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.07.009 · Cited by 179
Suzuki, S., Shibata, N., Yamane, K., Wachino, J.-I., Ito, K., & Arakawa, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn463 · Cited by 178
Epidemiology of Conjugative Plasmid-Mediated AmpC β-Lactamases in the United States
Alvarez, M., Tran, J. H., Chow, N., & Jacoby, G. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.533-537.2004 · Cited by 178
Global spread of New Delhi metallo-β-lactamase 1
Hammerum, A. M., Toleman, M. A., Hansen, F., Kristensen, B., Lester, C. H., Walsh, T. R., & Fuursted, K. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70276-0 · Cited by 173
Lascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
Clinical significance of extended-spectrum β-lactamases
Rodríguez-Baño, J., & Pascual, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.671 · Cited by 163
Peirano, G., van der Bij, A. K., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06025-11 · Cited by 153
Self-citationMolecular Characterization of Cefoxitin-Resistant Escherichia coli from Canadian Hospitals
Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E., & Paton, S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.358-365.2005 · Cited by 151
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Self-citationPeirano, G., Schreckenberger, P. C., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-10 · Cited by 131
Self-citationMoland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., & Thomson, K. S. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00756-06 · Cited by 126
Virulence factors of septicemic Escherichia coli strains
Mokady, D., Gophna, U., & Ron, E. Z. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.07.007 · Cited by 91
Kim, J., Bae, I. K., Jeong, S. H., Chang, C. L., Lee, C. H. E., & Lee, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr106 · Cited by 83
Global spread of New Delhi mettallo-beta-lactamase-1(NDM-1).
Fallah, F., Taherpour, A., Hakemi-Vala, M., & Hashemi, A. (2011) · Archives of Clinical Infectious Diseases · Cited by 79
Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
Pitout, J. D. D. (2007) · Emerging infectious diseases · doi:10.3201/eid1303.060447 · Cited by 72
Self-citationJones, G., Warren, R. E., Skidmore, S., Davies, V. A., Gibreel, T. M., & Upton, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn406 · Cited by 65
van der Bij, A. K., Peirano, G., Goessens, W. H. F., van der Vorm, E. R., van Westreenen, M., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00074-11 · Cited by 60
Self-citationMorris, D., Boyle, F., Ludden, C., Condon, I., Hale, J. L., O’Connell, N. H., Power, L., Boo, T. W., Dhanji, H., Lavallée, C., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05127-11 · Cited by 52
Stone, N. R. H., Woodford, N., Livermore, D. M., Howard, J. C., Pike, R., Mushtaq, S., Perry, C., & Hopkins, S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr337 · Cited by 44
Mihaïla-Amrouche, L., Wyplosz, B., Clermont, O., Garry, L., Hipeaux, M. C., Vittecoq, D., Dussaix, É., Denamur, É., & Branger, C. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq155 · Cited by 34
Mantengoli, E., Luzzaro, F., Pecile, P., Cecconi, D., Cavallo, A., Attala, L., Bartoloni, A., & Rossolini, G. M. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq194 · Cited by 27
Cited by
Urinary Tract Infection Syndromes
Foxman, B. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.09.003 · Cited by 1,333
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Self-citationEwers, C., Bethe, A., Semmler, T., Guenther, S., & Wieler, L. H. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03850.x · Cited by 677
Methane as a Resource: Can the Methanotrophs Add Value?
Strong, P. J., Xie, S., & Clarke, W. P. (2015) · Environmental Science & Technology · doi:10.1021/es504242n · Cited by 501
Price, L. B., Johnson, J. R., Aziz, M., Clabots, C., Johnston, B., Tchesnokova, V., Nordstrom, L., Billig, M., Chattopadhyay, S., Stegger, M., et al. (2013) · mBio · doi:10.1128/mbio.00377-13 · Cited by 464
Metadata
- Authors
- Pitout, J. D. D.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 9-9
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2112874950
- Cited by
- 473
- References
- 54
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.